Both cGAS and STING have been found to be expressed in 54.4% and 45.5% of human melanoma and colorectal cancer cell lines, respectively; and cells defective for the cGAS–STING pathway are sensitive to oncolytic DNA virus (Xia et al., 2016a,b). This evidence concerns the gene STING1 and melanoma.